Healthcare provider profile · identity verified

Veronica E Lorenzo, MD

Family Practice · SAGINAW, MI · NPI 1326036815

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	349	115
Levothyroxine Sodium	Levothyroxine Sodium	347	122
Amlodipine Besylate	Amlodipine Besylate	289	98
Lisinopril	Lisinopril	238	88
Gabapentin	Gabapentin	211	47
Simvastatin	Simvastatin	207	78
Metoprolol Succinate	Metoprolol Succinate	205	70
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	198	52
Metformin Hcl	Metformin Hcl	195	73
Metoprolol Tartrate	Metoprolol Tartrate	146	47
Omeprazole	Omeprazole	146	55
Hydrochlorothiazide	Hydrochlorothiazide	142	55
Rosuvastatin Calcium	Rosuvastatin Calcium	140	48
Jardiance	Empagliflozin	123	28
Losartan Potassium	Losartan Potassium	115	38
Famotidine	Famotidine	107	44
Trazodone Hcl	Trazodone Hcl	103	30
Glipizide	Glipizide	101	30
Furosemide	Furosemide	99	36
Ozempic	Semaglutide	96	23
Pantoprazole Sodium	Pantoprazole Sodium	95	36
Allopurinol	Allopurinol	92	33
Sertraline Hcl	Sertraline Hcl	91	38
Montelukast Sodium	Montelukast Sodium	88	32
Trulicity	Dulaglutide	87	19
Atenolol	Atenolol	83	26
Eliquis	Apixaban	78	16
Lorazepam	Lorazepam	78	22
Tramadol Hcl	Tramadol Hcl	78	22
Escitalopram Oxalate	Escitalopram Oxalate	74	26
Albuterol Sulfate Hfa	Albuterol Sulfate	69	35
Donepezil Hcl	Donepezil Hcl	64	25
Buspirone Hcl	Buspirone Hcl	60	19
Ropinirole Hcl	Ropinirole Hcl	60	16
Citalopram Hbr	Citalopram Hydrobromide	58	23
Potassium Chloride	Potassium Chloride	58	26
Alprazolam	Alprazolam	57	15
Meloxicam	Meloxicam	56	16
Clopidogrel	Clopidogrel Bisulfate	55	20
Duloxetine Hcl	Duloxetine Hcl	55	17
Fluoxetine Hcl	Fluoxetine Hcl	55	17
Fluticasone Propionate	Fluticasone Propionate	54	28
Glipizide Er	Glipizide	46	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	17
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Alendronate Sodium	Alendronate Sodium	42	13
Carvedilol	Carvedilol	42	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	39	15
Tizanidine Hcl	Tizanidine Hcl	39	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	14
Pravastatin Sodium	Pravastatin Sodium	38	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	13
Metformin Hcl Er	Metformin Hcl	36	12
Ondansetron Odt	Ondansetron	33	11
Meclizine Hcl	Meclizine Hcl	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	27	11
Triamcinolone Acetonide	Triamcinolone Acetonide	27	20
Diazepam	Diazepam	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Raloxifene Hcl	Raloxifene Hcl	23	suppressed
Lovastatin	Lovastatin	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Prednisone	Prednisone	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Azithromycin	Azithromycin	16	12
Ibuprofen	Ibuprofen	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Fluconazole	Fluconazole	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Topiramate	Topiramate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error